Latest Perspectives

• June 21

  2022

  US FTC Takes Aim at Pharmaceutical Rebates

• June 13

  2022

  FTC May Issue Policy Statement on Rebates, Fees for Excluding Lower Cost Drug Products

  Pharma Cos. Should Consider Reviewing Rebate Contracts with 6 PBMs in Advance

• May 03

  2022

  Amgen Inc. v. Sanofi: Does the Supreme Court’s Call for the Solicitor General’s Views Signal an Intention to Resolve Important Enablement Questions for Genus Claims?

  Immuno-Innovation Blog